Air/liquid interface cultures for alveolar type II cell differentiation
Air/liquid interface cultures for alveolar type II cell differentiation
批准号:
8279217
负责人:
ROBERT James MASON
金额:
$19.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2014-06-30
关键词:
ABCA3 geneADD-1 proteinAcute Lung InjuryAcyltransferaseAddressAdultAdult Respiratory Distress SyndromeAirAlveolarApicalAreaBreathingCCAAT-Enhancer-Binding ProteinsCell Culture TechniquesCell Differentiation processCell RespirationCell physiologyCellsCitratesComplexCulture MediaCytoplasmDevelopmentDiffusionEpithelialExcisionFatty AcidsFatty-acid synthaseGasesGene Expression RegulationGene ProteinsGene TargetingGenesGenomicsGoalsGrantHumanImpairmentLeadLipidsLiquid substanceLungLung diseasesLysophosphatidylcholinesMediatingMetabolicMitochondriaNuclearOxygenPDPK1 genePathway interactionsPeroxisome Proliferator-Activated ReceptorsPhospholipidsPneumoniaProcessProcollagen-Proline DioxygenaseProductionProteinsPulmonary EdemaPulmonary SurfactantsRegulationRodentRoleSLC2A1 geneSRE-1 binding proteinStearoyl-CoA DesaturaseSystemType I Epithelial Receptor CellType II Epithelial Receptor CellVascular Endothelial Growth Factorsalveolar type II cellbasedeacylationdensityfactor Chuman FRAP1 proteinhypoxia inducible factor 1improvedin vivoinsightlipid biosynthesisnew therapeutic targetnovelresearch studysurfactanttissue culturetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pulmonary surfactant is known to be critical for gas exchange and for maintaining patency of small airways. However, regulation of surfactant production in the adult lung is not completely understood. There is currently no known pharmacologic means to increase endogenous surfactant production in vivo for the treatment of lung diseases. We recently revisited the use of air/liquid interface cultures (no apical fluid) in the primary culture of type II cells. We found that the addition of apical fluid rapidly (<48 h) reduces surfactant protein levels and removal of all apical fluid rapidly (<48 h) restores surfactant protein levels. The purpose of this R21 grant is to discover the mechanism for this effect. We propose that the mechanism is oxygen sensing by prolyl hydroxylase 2 (PHD2) and that the effect is HIF1a mediated. We find that in submerged cultures there is an increase in nuclear HIF1a and HIF2, an increase in HIF responsive genes, the effect is reproduced by the HIF stabilizer, DMOG, and that the effect is blocked by supplemental oxygen. The downstream alterations likely include inhibiting two key transcription factors C/EBPa and SREBP-1. However, we are mindful that other pathways are also likely involved, and we will examine TTF1, FOXA2, mTOR, PPAR? and AMPK target genes in the analyses of the microarray experiments. Our initial focus will be on HIF1a, C/EBP1, and SREBP-1c responsive genes, since they are likely to be involved. We have significantly improved our type II cell cultures so all the studies in this proposal will be human type II cells. We will address both surfactant protein and phospholipid synthesis. We believe that the deacylation-reacylation remodeling pathway for dipalmitoylphosphatidylchoine (DPPC) is less active in human cells than in rodent cells based on the regulation of gene expression of lysophosphatidylcholine acyltransferase (LPCAT1). The goal of this study is to define the regulation of surfactant production in adult human type II cells. This study should also indicate that sustained pulmonary edema will impair type I cell function and provide another reason for the use of supplemental oxygen in acute lung injury.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bbrc.2014.09.060
发表时间:
2014-10-03
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Ito, Yoko, Zernans, Rachel, Correll, Kelly, Yang, Ivana V., Ahmad, Aftab, Gao, Bifeng, Mason, Robert J.]
通讯作者:
Mason, Robert J.
Air/liquid interface cultures for alveolar type II cell differentiation
-
批准号:8191639
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2011
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:8074270
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:8063939
-
项目类别:
-
资助金额:$43.4万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:8260411
-
项目类别:
-
资助金额:$43.38万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:7679879
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:7787530
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar type II cell innate immune response to influenza
-
批准号:8456892
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2009
-
负责人:ROBERT James MASON
-
依托单位:
DE PEDIATRIC COBRE: CELL SCIENCE CORE
-
批准号:7720949
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2008
-
负责人:ROBERT James MASON
-
依托单位:
DE PEDIATRIC COBRE: CELL SCIENCE CORE
-
批准号:7610721
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2007
-
负责人:ROBERT James MASON
-
依托单位:
DE PEDIATRIC COBRE: CELL SCIENCE CORE
-
批准号:7382170
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2006
-
负责人:ROBERT James MASON
-
依托单位:
DE PEDIATRIC COBRE: CELL SCIENCE CORE
-
批准号:7171395
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2005
-
负责人:ROBERT James MASON
-
依托单位:
CORE--DE PEDIATRIC COBRE: CELL SCIENCE CORE
-
批准号:6973095
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2004
-
负责人:ROBERT James MASON
-
依托单位:
Type II Pneumocyte Interactions with SARS-CoV
-
批准号:6797025
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2003
-
负责人:ROBERT James MASON
-
依托单位:
Conference:Lung Surfactant:Cellular & Molecular Biology
-
批准号:6507112
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2002
-
负责人:ROBERT James MASON
-
依托单位:
Alveolar epithelium in pulmonary fibrosis
-
批准号:6616356
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2002
-
负责人:ROBERT James MASON
-
依托单位:
SCOR: Pathobiology of Fibrotic Lung Disease
-
批准号:6785314
-
项目类别:
-
资助金额:$183.09万
-
财政年份:2001
-
负责人:ROBERT James MASON
-
依托单位:
SCOR: Pathobiology of Fibrotic Lung Disease
-
批准号:6912712
-
项目类别:
-
资助金额:$188.58万
-
财政年份:2001
-
负责人:ROBERT James MASON
-
依托单位:
SCOR: Pathobiology of Fibrotic Lung Disease
-
批准号:6573340
-
项目类别:
-
资助金额:$173.22万
-
财政年份:2001
-
负责人:ROBERT James MASON
-
依托单位:
SCOR: Pathobiology of Fibrotic Lung Disease
-
批准号:6346865
-
项目类别:
-
资助金额:$169.52万
-
财政年份:2001
-
负责人:ROBERT James MASON
-
依托单位:
SCOR: Pathobiology of Fibrotic Lung Disease
-
批准号:6616116
-
项目类别:
-
资助金额:$177.76万
-
财政年份:2001
-
负责人:ROBERT James MASON
-
依托单位: